BioNTech: Follow-on Offering Funding Round

BioNTech has successfully raised $325M in Follow-on Offering funding, reaching a valuation of $45B.

Company Overview

Immunotherapy and mRNA vaccines

Funding Details

The Follow-on Offering round was led by Strüngmann Family Office, with participation from MIG, Salvia, AT Impf, Pfizer.

Company Information

• Headquarters: An der Goldgrube 12, Mainz 55131, Germany
• Founded: 2008
• Employees: 5000+
• Category: Biotech

Investment

BioNTech plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

• Strüngmann Family Office: Verified investor in Follow-on Offering
• MIG: Verified investor in Follow-on Offering
• Salvia: Verified investor in Follow-on Offering
• AT Impf: Verified investor in Follow-on Offering
• Pfizer: Verified investor in Follow-on Offering